Avastin® (bevacizumab)

DRUG3 trials

Sponsors

Massachusetts General Hospital, Reza Dana, MD

Conditions

Corneal Graft FailureCorneal NeovascularizationRecurrent Respiratory Papillomatosis

Phase 1

Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)

CompletedNCT01020747

Massachusetts General HospitalRecurrent Respiratory Papillomatosis

Start: 2009-11-30End: 2011-03-31Updated: 2012-12-20

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

CompletedNCT01072357

Reza Dana, MDCorneal Graft Failure, Corneal Neovascularization

Start: 2009-12-31End: 2015-01-31Updated: 2018-06-15

A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

CompletedNCT01996826

Reza Dana, MDCorneal Graft Failure, Corneal Neovascularization

Start: 2014-04-30End: 2019-04-30Updated: 2020-08-10